Open access · CC-BY
via OpenAlex
Metformin: A stroke of luck
Mohamad Aljofan, Abduzhappar Gaipov
Electronic Journal of General Medicine · 2019 · ▲ 9 citations
Abstract
Metformin is an oral glucose-lowering drug that has been widely used for more than half a century. Both the American Diabetes Association and the European Association for the study of Diabetes recommend metformin as the first line therapy for the treatment of type II diabetes mellitus. Metformin has considerably evolved from being an antidiabetic into a drug with a wider potential of therapeutic uses such as anticancer, antiaging, treatment of gestational hypertension, preeclampsia and weight loss. In addition to the in-label use of metformin as an anti-hyperglycemic medication, it is widely prescribed as an off label therapy for young women with Poly Cystic Ovary Syndrome for the treatment of symptoms associated with the disorder. This article is a brief summary that lists and briefly discusses current and potential non-hyperglycemic uses and effects of metformin.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.29333/ejgm/108679
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
Aljofan, M., & Gaipov, A. (2019). Metformin: A stroke of luck. <em>Electronic Journal of General Medicine</em>. https://doi.org/10.29333/ejgm/108679
Vancouver
Aljofan M, Gaipov A. Metformin: A stroke of luck. Electronic Journal of General Medicine. 2019. doi:10.29333/ejgm/108679.
BibTeX
@article{mohamad2019Metfor,
title = {Metformin: A stroke of luck},
author = {Mohamad Aljofan and Abduzhappar Gaipov},
journal = {Electronic Journal of General Medicine},
year = {2019},
doi = {10.29333/ejgm/108679},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Education Health and Sport 2025
Open access · CC-BY
Metformin - An Antidiabetic Drug With Anti-aging, Cardioprotective And Potential Anti-cancer Properties
Diabetes Obesity and Metabolism 2024
Open access · CC-BY
Metformin beyond type 2 diabetes: Emerging and potential new indications
Current Medicinal Chemistry 2022
Open access · CC-BY
Repurposing Metformin for Vascular Disease
Vascular Health and Risk Management 2024
Open access · CC-BY
Repurposing Metformin for the Treatment of Atrial Fibrillation: Current Insights
Research Square 2024
Preprint · CC-BY
MicroRNAs Associated with Metformin Treatment in the Diabetes Prevention Program
IntechOpen eBooks 2020
Open access · CC-BY